Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study

被引:38
|
作者
Schmidt, Johanna [1 ]
Dahlgren, Eva [1 ]
Brannstrom, Mats [1 ]
Landin-Wilhelmsen, Kerstin [2 ]
机构
[1] Univ Gothenburg, Dept Obstet & Gynaecol, Sahlgrenska Acad, Gothenburg, Sweden
[2] Univ Gothenburg, Dept Internal Med, Endocrinol Sect, Gothenburg, Sweden
基金
瑞典研究理事会;
关键词
RISK-FACTORS; CARDIOVASCULAR-DISEASE; SYNDROME PCOS; LEAN WOMEN; MASS; AGE; OSTEOPOROSIS; METAANALYSIS; SEX; HYPERANDROGENISM;
D O I
10.1111/j.1365-2265.2012.04378.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Hyperandrogenism is one of the characteristic features of the polycystic ovary syndrome (PCOS). Androgens are important for bone mass. Studies on bone mineral density (BMD) and fractures in postmenopausal women with PCOS are lacking. The aim of this study was to investigate whether postmenopausal women with PCOS differ from controls regarding body composition, BMD and prevalence of fractures, and to compare women with PCOS with controls regarding correlations between total BMD and sex hormones. Design A prospective 21-year follow-up study. Anthropometry, hormonal measurements and questionnaires were performed in 1987 and in 2008. Fractures were X-ray-verified. BMD measurements were taken in 1992, using single-photon absorptiometry (SPA), and in 2008, using dual-energy X-ray absorptiometry (DXA), to also enable measurements of body composition. Patients Twenty-five women with PCOS (Rotterdam criteria), aged 6178 similar to years, and 68 randomly allocated age-matched controls. Measurements Body composition, BMD, fractures and sex steroids. Results At follow-up, the postmenopausal women with PCOS maintained a higher free androgen index (FAI), but had similar body fat, lean mass and BMD compared with controls. The hip circumference increased only in women with PCOS (P similar to<similar to 0.01), during follow-up. The fracture incidence was similar to that of controls (56% vs 41%, ns). In the controls, total BMD was positively correlated with oestradiol (R similar to=similar to 0.322, P similar to<similar to 0.01) and FAI (R similar to=similar to 0.307, P similar to<similar to 0.05) and negatively correlated with SHBG (R similar to=similar to-0.429, P similar to<similar to 0.001), but not in the women with PCOS. Conclusions Postmenopausal women with PCOS with persistently higher FAI had similar muscle mass, BMD and fracture incidence as controls during this long-term follow-up.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 50 条
  • [31] Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study
    Kassanos, D.
    Trakakis, E.
    Baltas, C. S.
    Papakonstantinou, O.
    Simeonidis, G.
    Salamalekis, G.
    Grammatikakis, I.
    Basios, G.
    Labos, G.
    Skarantavos, G.
    Balanika, A.
    HUMAN REPRODUCTION, 2010, 25 (08) : 2107 - 2114
  • [32] Bone mineral density loss in patients with urolithiasis:: A follow-up study
    Cvijetic, S
    Füredi-Milhofer, H
    Babic-Ivancic, V
    Tucak, A
    Galic, J
    Dekanic-Ozegovic, D
    ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (02) : 152 - 157
  • [33] Relationships Between Body Composition, Muscular Strength, and Bone Mineral Density in Estrogen-Deficient Postmenopausal Women
    Sherk, Vanessa D.
    Palmer, Ian J.
    Bemben, Michael G.
    Bemben, Debra A.
    JOURNAL OF CLINICAL DENSITOMETRY, 2009, 12 (03) : 292 - 298
  • [34] The relationship of body composition with bone mineral density and 10-year probability of hip fracture in postmenopausal women
    Li, Yan
    Xu, Zhenbin
    GERIATRIC NURSING, 2024, 59 : 250 - 255
  • [35] The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density
    Recknor, Christopher P.
    Recker, Robert R.
    Benson, Charles T.
    Robins, Deborah A.
    Chiang, Alan Y.
    Alam, Jahangir
    Hu, Leijun
    Matsumoto, Toshio
    Sowa, Hideaki
    Sloan, John H.
    Konrad, Robert J.
    Mitlak, Bruce H.
    Sipos, Adrien A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (09) : 1717 - 1725
  • [36] Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: A 5-year follow-up
    Tuppurainen, Marjo
    Harma, Kirsi
    Komulainen, Marja
    Kiviniemi, Vesa
    Kroger, Heikki
    Honkanen, Risto
    Alhava, Esko
    Jurvelin, Jukka
    Saarikoski, Seppo
    MATURITAS, 2010, 66 (04) : 423 - 430
  • [37] Long-Term Follow-Up of Patients With Short QT Syndrome
    Giustetto, Carla
    Schimpf, Rainer
    Mazzanti, Andrea
    Scrocco, Chiara
    Maury, Philippe
    Anttonen, Olli
    Probst, Vincent
    Blanc, Jean-Jacques
    Sbragia, Pascal
    Dalmasso, Paola
    Borggrefe, Martin
    Gaita, Fiorenzo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (06) : 587 - 595
  • [38] The relationship of total body composition with bone mineral density in postmenopausal women with type 2 diabetes
    Klimontov, V. V.
    Fazullina, O. N.
    DIABETES MELLITUS, 2015, 18 (01): : 65 - 69
  • [39] Late Effects and Long-Term Follow-Up after Cancer in Childhood
    Langer, Thorsten
    Grabow, Desiree
    Steinmann, Diana
    Woermann, Bernhard
    Calaminus, Gabriele
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (12) : 746 - 750
  • [40] Long-term changes in bone mineral density following adolescent idiopathic scoliosis surgery: a minimum 34-year follow-up
    Akazawa, Tsutomu
    Kotani, Toshiaki
    Sakuma, Tsuyoshi
    Iijima, Yasushi
    Torii, Yoshiaki
    Ueno, Jun
    Yoshida, Atsuhiro
    Eguchi, Yawara
    Inage, Kazuhide
    Matsuura, Yusuke
    Suzuki, Takane
    Niki, Hisateru
    Ohtori, Seiji
    Minami, Shohei
    EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY, 2024, 34 (01) : 425 - 431